Skip to main content

CPAG Steering Committee

The role of the Coalition of Patient Advocacy Groups (CPAG) Steering Committee is to help facilitate the development of activities that will benefit the entire CPAG membership. Those activities include (but are not limited to) webinars, in-person meetings, and one-on-one connections with other CPAG members and RDCRN researchers.

CPAG Steering Committee members make a commitment to attend monthly one-hour teleconference meetings and to participate collaboratively with other members on projects identified to help accelerate research as outlined in the CPAG vision and mission statements. In addition, CPAG Steering Committee members disseminate information and decisions from the CPAG Steering Committee meetings to PIs and other individual consortium PAG members in a timely manner.

CPAG Steering Committee


Patient Advocacy Group Representatives

2025-2026

CONSORTIUMNAMEEMAILPATIENT ADVOCACY GROUP
Advancing Craniosynostosis Treatment Rare Diseases Consortium (ACT)Carolina Sommercarolina@bornahero.orgBORN A HERO
Advancing Rare Disorders: Vascular mAlformation Research Network with CaNVAS (ARDVARC)Mellenee Fingermellenee@gmail.comK-T Support Group
Autoimmunity, Rasmussen’s, Inflammation & Status Epilepticus Research Network (ARISEN)Michael Devlinmichael.devlin@sumairafoundation.orgSumaira Foundation
Batten Disease Clinical Research Consortium (BDCRC)Suzanne Jamesdiette528@gmail.comBatten Disease Support & Research Association
Brain Vascular Malformation Consortium (BVMC)Marianne Clancymariannes.clancy@curehht.orgThe HHT Foundation International
Brittle Bone Disorders (BBD)Tracy Hartthart@oif.orgOsteogenesis Imperfecta Foundation, Inc.
Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe)Brian Linblin@mdausa.orgMuscular Dystrophy Association (MDA)
Congenital and Perinatal Infections Consortium (CPIC)Kristen Spytekkristen.spytek@nationalcmv.orgNational CMV Foundation
Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)Mary Jo Strobelmjstrobel@apfed.orgAmerican Partnership for Eosinophilic Disorders
Developmental Synaptopathies Consortium (DSC)Kristin Anthonykristin@ptenfoundation.orgPTEN Foundation
The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)

Erica Barnes

Melody Kiser

erica.barnes@state.mn.us

melody.kisor@scn2a.org

Chloe’s Fight Rare Disease Foundation

FamilieSCN2A Foundation

Initiation of a cohort to define pathogenic Mechanisms, Precision diagnosis And Complications of Thrombotic Microangiopathies: The IMPACT Study (IMPACT)Beth McGrawbeth@ustma.orgUnited States Thrombotic Microangiopathy (USTMA)
Myasthenia Gravis Rare Disease Network (MGNet)Allison Fossallisonfoss@mgakc.orgMyasthenia Gravis Association
Network for Advancing Sex Chromosome Aneuploidy Research Readiness (NASCARR)Erynn Fishmanerynn.fishman@gmail.comAssociation for X and Y Chromosome Variations (AXYS)
Phenylalanine Families and Researchers Exploring Evidence (PHEFREE)

Elaina Jurecki

Kelsey McQueen, Co-Chair

erjurecki@outlook.com

kmcqueen@npkua.org

National PKU Alliance
Porphyrias Consortium (PC)Kristen Wheedenkristen@porphyria.orgUnited Porphyrias Association
Primary Immune Deficiency Treatment Consortium (PIDTC)Chris Scalchunescscalchunes@primaryimmune.orgImmune Deficiency Foundation (IDF)
Urea Cycle Disorders Consortium (UCDC)Tresa Warnertwarner@nucdf.orgNational Urea Cycle Disorders Foundation (NUCDF)
Vasculitis Clinical Research Consortium (VCRC)Joyce A Kullmanjakullman@vasculitisfoundation.orgVasculitis Foundation

*In alphabetical order by consortium